Wave Life Sciences (WVE) Total Liabilities (2014 - 2026)

Wave Life Sciences' Total Liabilities history runs 13 years deep, the most recent figure standing at $71.8 million for Q1 2026.

• Quarterly Total Liabilities fell 33.91% year-over-year to $71.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $71.8 million (down 33.91% YoY) and the FY2025 annual result came in at $112.3 million, down 16.73% from the prior year.
• Total Liabilities was $71.8 million for Q1 2026 at Wave Life Sciences, down from $112.3 million in the prior quarter.
• Across five years, Total Liabilities topped out at $294.1 million in Q1 2023 and bottomed at $71.8 million in Q1 2026.
• A 5-year average of $175.3 million and a median of $178.2 million in 2022 frame the typical range for Total Liabilities.
• Annual changes were most pronounced in 2023 — Total Liabilities jumped 84.35% — and 2025, when it plunged 48.53%.
• Wave Life Sciences' Total Liabilities stood at $183.6 million in 2022, then grew by 23.88% to $227.4 million in 2023, then plunged by 40.73% to $134.8 million in 2024, then slipped by 16.73% to $112.3 million in 2025, then slumped by 36.03% to $71.8 million in 2026.
• Business Quant data shows WVE's Total Liabilities at $71.8 million in Q1 2026, $112.3 million in Q4 2025, and $109.0 million in Q3 2025.